A PYMNTS Company

DG Competition’s Preliminary Report on the Pharma Sector Inquiry: A Need for Clear Signals at the IP/Competition Intersection

BY | February 25, 2009

This article is part of a Chronicle. See more from this Chronicle David Hull, Feb 25, 2009 Much of the discussion at the time of the Report’s release and since…

This article is part of a Chronicle. See more from this Chronicle

David Hull, Feb 25, 2009

Much of the discussion at the time of the Report’s release and since has revolved around the European regime governing the recognition and enforcement of patents. Intellectual property experts are troubled by inaccuracies in the Report as well as by suggestions that practices that are common not just in the pharmaceutical sector, but all high-tech sectors, such as taking out numerous patents around a

...
THIS ARTICLE IS NOT AVAILABLE FOR IP ADDRESS 44.210.99.209

Please verify email or join us to access premium content!